Society Of Urologic Oncology Clinical Trials Consortium
EIN: 262943602 · Schaumburg, IL · NTEE: H30
| Metric | Value |
|---|---|
| Total Revenue | $554K |
| Total Expenses | $238K |
| Net Assets | $1.1M |
Is Society Of Urologic Oncology Clinical Trials Consortium Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Society Of Urologic Oncology Clinical Trials Consortium
Society Of Urologic Oncology Clinical Trials Consortium (EIN: 262943602) is a nonprofit organization based in Schaumburg, IL, classified under NTEE code H30. The organization reported total revenue of $554K and total assets of $1.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Society Of Urologic Oncology Clinical Trials Consortium's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Society Of Urologic Oncology Clinical Trials Consortium is a small nonprofit that has been operating for 16 years, with 12 years of IRS 990 filings on record (2012–2023). Revenue has grown at a compound annual rate of 6.5%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $332K |
| Total Expenses | $238K |
| Surplus / Deficit | +$94K |
| Total Assets | $1.1M |
| Total Liabilities | $33K |
| Net Assets | $1.1M |
| Operating Margin | 28.4% |
| Debt-to-Asset Ratio | 3.0% |
| Months of Reserves | 55.8 months |
Financial Health Grade: A
In 2023, Society Of Urologic Oncology Clinical Trials Consortium reported a surplus of $94K with revenue exceeding expenses, holds 55.8 months of operating reserves (strong position), has a debt-to-asset ratio of 3.0% (very low leverage).
Financial Trends
Over 12 years of filings (2012–2023), Society Of Urologic Oncology Clinical Trials Consortium's revenue has grown at a compound annual growth rate (CAGR) of 6.5%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -47.0% | +29.6% | +8.4% |
| 2022 | +185.5% | +19.1% | +81.8% |
| 2021 | +2.7% | -5.6% | +12.9% |
| 2020 | -17.4% | +2.0% | +15.1% |
| 2019 | -11.4% | +8.3% | +28.8% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2010 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Society Of Urologic Oncology Clinical Trials Consortium has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Society Of Urologic Oncology Clinical Trials Consortium with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $94K, with revenue exceeding expenses.
- Debt-to-asset ratio: 3.0%.
Frequently Asked Questions about Society Of Urologic Oncology Clinical Trials Consortium
Is Society Of Urologic Oncology Clinical Trials Consortium a legitimate charity?
Society Of Urologic Oncology Clinical Trials Consortium (EIN: 262943602) is a registered tax-exempt nonprofit based in Illinois. It has 12 years of IRS 990 filings on record. Total revenue: $554K. No red flags identified. Financial health grade: A.
How does Society Of Urologic Oncology Clinical Trials Consortium spend its money?
Society Of Urologic Oncology Clinical Trials Consortium reported $554K in total revenue in IRS 990 filings. 12 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Society Of Urologic Oncology Clinical Trials Consortium tax-deductible?
Society Of Urologic Oncology Clinical Trials Consortium is registered as a tax-exempt nonprofit (EIN: 262943602). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Society Of Urologic Oncology Clinical Trials Consortium located?
Society Of Urologic Oncology Clinical Trials Consortium is headquartered in Schaumburg, Illinois and files with the IRS under EIN 262943602. It is classified under NTEE code H30.
How many years of IRS 990 filings does Society Of Urologic Oncology Clinical Trials Consortium have?
Society Of Urologic Oncology Clinical Trials Consortium has 12 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $554K in total revenue.
Filing History
IRS 990 filing history for Society Of Urologic Oncology Clinical Trials Consortium showing financial trends over 12 years of public records:
Over 12 years of IRS 990 filings (2012–2023), Society Of Urologic Oncology Clinical Trials Consortium's revenue has grown by 99.9%, moving from $166K to $332K. Total assets increased by 26180.6% over the same period, from $4K to $1.1M. Total functional expenses rose by 59.7%, from $149K to $238K. In its most recent filing year (2023), Society Of Urologic Oncology Clinical Trials Consortium reported a surplus of $94K, with revenue exceeding expenses. The organization holds $33K in liabilities against $1.1M in assets (debt-to-asset ratio: 3.0%), resulting in net assets of $1.1M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $332K | $238K | $1.1M | $33K | — | View 990 |
| 2022 | $627K | $184K | $1.0M | $41K | — | View 990 |
| 2021 | $220K | $154K | $561K | $25K | — | View 990 |
| 2020 | $214K | $163K | $497K | $26K | — | View 990 |
| 2019 | $259K | $160K | $431K | $12K | — | View 990 |
| 2018 | $292K | $148K | $335K | $14K | — | View 990 |
| 2017 | $225K | $163K | $188K | $11K | — | View 990 |
| 2016 | $124K | $148K | $130K | $15K | — | View 990 |
| 2015 | $163K | $156K | $156K | $17K | — | View 990 |
| 2014 | $164K | $135K | $131K | $0 | — | View 990 |
| 2013 | $226K | $128K | $102K | $0 | — | View 990 |
| 2012 | $166K | $149K | $4K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $332K, expenses of $238K, and assets of $1.1M (revenue -47.0% year-over-year).
- 2022: Revenue of $627K, expenses of $184K, and assets of $1.0M (revenue +185.5% year-over-year).
- 2021: Revenue of $220K, expenses of $154K, and assets of $561K (revenue +2.7% year-over-year).
- 2020: Revenue of $214K, expenses of $163K, and assets of $497K (revenue -17.4% year-over-year).
- 2019: Revenue of $259K, expenses of $160K, and assets of $431K (revenue -11.4% year-over-year).
- 2018: Revenue of $292K, expenses of $148K, and assets of $335K (revenue +29.8% year-over-year).
- 2017: Revenue of $225K, expenses of $163K, and assets of $188K (revenue +81.5% year-over-year).
- 2016: Revenue of $124K, expenses of $148K, and assets of $130K (revenue -24.1% year-over-year).
- 2015: Revenue of $163K, expenses of $156K, and assets of $156K (revenue -0.4% year-over-year).
- 2014: Revenue of $164K, expenses of $135K, and assets of $131K (revenue -27.6% year-over-year).
- 2013: Revenue of $226K, expenses of $128K, and assets of $102K (revenue +36.2% year-over-year).
- 2012: Revenue of $166K, expenses of $149K, and assets of $4K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Society Of Urologic Oncology Clinical Trials Consortium:
Data Sources and Methodology
This transparency report for Society Of Urologic Oncology Clinical Trials Consortium is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.